Gouty Offense in Patients With Obstructive Coronary Artery Disease Despite State-of-the-Art Therapy.

For example, a cross‐sectional, retrospective study of 1200 patients with gout demonstrated that treatment with colchicine, a general anti‐inflammatory agent, resulted in a significantly lower prevalence of MI and a clear trend towards reduced all‐cause mortality compared with patients who did not take colchicine. 2 Additionally, a randomized clinical trial evaluated the effects of canakinumab, an anti‐IL‐1β monoclonal antibody, on the occurrence and degree of gout symptoms.

also in 19,460 other papers